A Principal Component Analysis (PCA) was applied to a dataset comprising gene expression data from ER+ BRCA, AR+ TNBC and PRAD tumor tissue samples, along normal tissue samples from breast and prostate patients. This evidence concerns the gene ESR1 and prostate adenocarcinoma.